Fights to Hide Data on Deadly Adverse Drug Effects

LILLY FIGHTS TO HIDE DATA ON DEADLY ADVERSE DRUG EFFECTS 

On June 15, 2005, in a multicase product liability suit, Eli Lilly settled for 690 million. Most of the case involved life-threatening diabetes caused by Zyprexa. I was hired as a medical expert by Hersh and Hersh, a California law firm involved in that multisuit, multistate legal action, and had the opportunity to evaluate sometimes lethal cases of diabetes and pancreatitis caused by Zyprexa. Some cases became chronic other patients died within hours of onset. My Web site (http //www.breggin.com) contains more details on the Eli Lilly settlement. Meanwhile, similar cases have continued to be brought with potential payouts, or settlements, by the company estimated at 1.2 billion (Rosack, 2007). 

Although Eli Lilly denies any wrongdoing whatsoever in the Zyprexa diabetes and pancreatitis cases, why would a company pay more than a billion dollars just to get the lawyers to drop false charges That is hardly a nuisance settlement it is a mammoth settlement. The answer lies in the part of the agreement that allows all of the incriminating documents to remain sealed. 

---